Xiaoyuan (Sharon) Li

Title: Innovations by Inventor Xiaoyuan (Sharon) Li

Introduction

Xiaoyuan (Sharon) Li is a prominent inventor based in Los Altas, California. He holds a total of two patents that contribute significantly to the field of medicinal chemistry, particularly in the development of protein kinase inhibitors. His work has important implications for therapeutic applications in various diseases.

Latest Patents

Li's latest patents focus on aminoheteroaryl compounds as protein kinase inhibitors. These include aminopyridine and aminopyrazine compounds, described in formula (1). These compounds not only showcase activity as protein kinase inhibitors but are also effective against c-MET, a known target in cancer therapy. The compositions and methods of use associated with these compounds promise innovative approaches to treating various medical conditions.

Career Highlights

Throughout his professional journey, Xiaoyuan (Sharon) Li has made significant contributions while working with notable companies, including Pfizer Corporation and Sugen Incorporated. His experience in these leading pharmaceutical organizations has provided him with a robust platform for research and innovation, enabling him to push the boundaries in drug development.

Collaborations

Li has also had the opportunity to collaborate with talented individuals in his field, including Jingrong Jean Cui and Dilip Ramakant Bhumralkar. These collaborations have enhanced his research endeavors and have been instrumental in furthering his contributions to the development of novel therapeutic agents.

Conclusion

Xiaoyuan (Sharon) Li's work in the field of protein kinase inhibitors showcases the potential of innovative compounds in medical research. Through his patents and professional collaborations, he continues to influence the landscape of drug development and therapeutic strategies, building a legacy that underscores the importance of invention in addressing healthcare challenges.